Clinical Trials Browser

Recruiting × Recurrence × Irinotecan × Clear all

NCT01356290 2026-02-23

MEMMAT

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

NCT06208657 2026-01-28

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Phase 1/2 Recruiting

Lymphoma, Neoplasms, Recurrence, Central Nervous System Neoplasms